About the GHIT Fund

Board of Directors

  • Representative Director and Chair Kiyoshi Kurokawa, MD Professor Emeritus, National Graduate Institute for Policy Studies
    Chairman, Health and Global Policy Institute

    A graduate of University of Tokyo Faculty of Medicine, Dr. Kurokawa was a professor of medicine in the School of Medicine at UCLA (1979-84) and at the University of Tokyo (1989-96). He also served as Dean of Tokai University School of Medicine (1996-2002), President of Science Council of Japan (2003-06), Science Advisor to the Prime Minister (2006-08), and WHO Commissioner (2005-09). He is currently an executive member of many national and international professional societies,.
    His website:www.kiyoshikurokawa.com/en
  • Vice Chair Peter Piot, MD, PhD Director and Professor of Global Health,
    London School of Hygiene and Tropical Medicine,

    Peter Piot is Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. He was also founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995-2008), and has served in numerous other international and academic leadership roles. He sits on numerous boards and has received numerous scientific and civic awards, including the Canada Gairdner Global Health Award, Robert Koch Gold medal, and Prix International INSERM, Paris. He was a 2014 TIME Person of the Year (The Ebola Fighters), and received the Prince Mahidol Award for Public Health. In 2013 he was the laureate of the Hideyo Noguchi Africa Prize for Medical Research. Professor Piot co-discovered the Ebola virus in Zaire in 1976, and led research on AIDS, women's health, and public health in Africa. He was knighted as a baron in his native Belgium, and received an honorary knighthood in the U.K. He has published over 500 scientific articles and 16 books.
  • Executive Director BT Slingsby, MD, PhD, MPH CEO, Global Health Innovative Technology Fund

    Dr. Slingsby is CEO & Executive Director of the GHIT Fund — the World's first public-private fund focused on the development of new medicines for low- and middle-income countries. Previously, he was the global head for access strategies at Eisai Co., Ltd. where he developed new business models for R&D and overlooked market access in the developing world. Dr. Slingsby has helped launch numerous start-ups in Japan and the U.S., and currently advises at the Graduate School of Medicine at the University of Tokyo and Kyoto University. He is a member of the Public-Private Partnership Forum at the National Academy of Medicine in the U.S. and the Global Health and Human Security Program, and has published over 50 peer-reviewed articles on medicine and public health in both Japanese and, American literature. Dr. Slingsby graduated from Brown University, earned his Masters and Doctorate from Kyoto University, and the University of Tokyo, and received his Medical Doctorate from the George Washington University.
  • Member Mahima Datla Managing Director, Biological E. Limited

    Ms. Mahima Datla is Managing Director of Biological E. Over the past 13 years at BE, she has been involved in strategy and has also served as Senior Vice President of the company. She is currently responsible for strategic operations and projects. She drives Biological E.’s engagement with Government of India as well as the DCVMN and has been a GAVI board member since 2011. She is a graduate in Business Administration Management from Webster University, London.
  • Member Toru Kajiwara Director, Office of Global Health Cooperation
    Ministry of Health, Labour and Welfare

    Toru Kajiwara graduated from University of Oxford in 2001 with M.Phil in International Relations, and currently serves as Director of the Office of International Cooperation at the Ministry of Health, Labour and Welfare. Prior to his current assignment, he served as Counsellor at Permanent Mission of Japan to UNESCO (2014-2017) in Paris, and as Deputy Director at International Economy / OECD / European Union Economic Affairs Divisions (2013-2014), as well as the Southeast Asia Division (2010-2012) at the Ministry of Foreign Affairs. From 2006 to 2008, Mr. Kajiwara worked as Advisor at the Office of Executive Director for Japan in the World Bank Group in Washington DC. He was also involved in UN Security Council affairs and African development in his earlier careers at the Foreign Ministry.
  • Member Daikichi Momma Former Director -General, International Bureau, Ministry of Finance
    Former President, Policy and Research Institute, Ministry of Finance
    Former Executive Director of, International Monetary Fund representing Japan

    Mr. Momma worked for the Ministry of Finance (MOF), Cabinet Office, and Ministry of Defense covering various responsibilities including budget, tax, finance, international finance, multilateral development banks, external aid, global health, and national securities issues. He also served as Counsellor, Permanent Delegation of Japan to OECD, and Senior Advisor to Executive Director of World Bank Group representing Japan. He has in-depth experiences and knowledge particularly in the fields of international economic cooperation and development assistance to the developing countries. Mr. Momma currently assumes several positions including Special Researcher at MOF’s Policy Research Institute, Senior Research Advisor at the Institute for International Policy Studies, Vice President of the Association of African Economy & Development Japan, Executive Director of Japan Myanmar Association, and Executive Advisor to Nippon Life Insurance Company.
  • Member Manabu Sumi Director, Global Health Policy Division, International Cooperation Bureau
    Ministry of Foreign Affairs

  • Member Ann M. Veneman, JD Former Executive Director, UNICEF
    Former Secretary, United States Department of Agriculture

    Ann M. Veneman has a distinguished career in public service, including serving as Executive Director of the United Nations Children’s Fund (UNICEF) (2005-2010) and as the United States Secretary of Agriculture (2001-2005). Ms. Veneman graduated from the University of California, Davis, received a master’s degree in public policy from the University of California, Berkeley, and a juris doctor degree from the University of California, Hastings College of the Law. In 2009 she was named to the Forbes 100 Most Powerful Women list.
  • Supervisory Board Member Hikaru Ishiguro, LLM Board Member, Health and Global Policy Institute

    Hikaru Ishiguro is Board Member of Health and Global Policy Institute. Mr. Ishiguro is a graduate of the University of Tokyo and holds a LLM from Harvard Law School. Starting with Sumitomo Bank, he worked with a variety of global financial institutions. Mr. Ishiguro became Comptroller of the University of Tokyo in 2004 upon its incorporation and served in this role for 8 years. He is a member of the New York Sate Bar Association.
  • Supervisory Board Member Ko-Yung Tung, JD Lecturer at Law, Harvard Law School
    Former Senior Vice President and General Counsel of the World Bank

    Professor. Ko-Yung Tung is an international lawyer, with extensive experience in both the public and private sectors. He has served as Senior Vice President and General Counsel of the World Bank, where he was instrumental in establishing The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Secretary General of The International Centre for the Settlement of Investment Disputes (ICSID). He is Lecturer at Law at Harvard Law School where he teaches a course on international law. He practiced law at the international law firms of Morrison & Foerster, O’Melveny & Myers, and Debevoise & Plimpton. The GHIT Board benefits particularly from his expertise in international organizations, development and corporate governance. He received his undergraduate degree in physics from Harvard University and his law degree from Harvard Law School, and did graduate studies at the University of Tokyo, Faculty of Law.
  • Ex-Officio Kim C. Bush Senior Advisor, Life Sciences Partnerships, Bill & Melinda Gates Foundation

    Kim C. Bush is Senior Advisor of Life Sciences Partnerships for the Bill & Melinda Gates Foundation. He joined the foundation in September 2011 after completing a 30-year career at Baxter International that included multiple assignments leading the Vaccine, Bio-Therapeutic, and Medical Device related sector businesses.
  • Ex-Officio Richard Seabrook, PhD, MBA CEO, 360Biomedical Ltd
    Senior Advisor, Innovations, Wellcome Trust
    Previously, Head, Business Development, Innovations, Wellcome Trust

    Richard previously led the Business Development Team at Wellcome which, in addition to undertaking substantive transactions and IP prosecution, managed £750M of product development translational funding put to work with industry, SMEs, not for profits and universities. Key outcomes include the discovery of KAE609, Plazomicin, Ridinilazole and Xanamem, multiple phase 2 studies in progress and discovery and commercialisation of the molecular diagnostic platform SAMBA . He was a Non-Executive Director for Wellcome Trust Trading Ltd and Wellcome International Ltd, board Observer for the Wellcome Trust Sanger Institute parent company. Currently Richard runs his own advisory business, 360Biomedical Ltd, undertaking due diligence, business and corporate development for both the private and public sectors.